INORGANIC AND NANO-METAL CHEMISTRY
9
Another advantage of this method is the synthesis of some
new derivatives of dibenzo[c]acridines and 2-amino-
4H-chromenes.
Physical and spectra data for new compounds
10,10-Dimethyl-7-(4-isopropylphenyl)-9,10,11,12-tetrahydro-
benzo[c]acridin-8(7H)-one (4k). Melting point: 214–216 ꢀC:
withe powder, IR (KBr, cmꢂ1): 3321, 3060, 2897, 1667, 1567,
1522, 1435, 1340, 1275, 815; 1H NMR (300 MHz, CDCl3)
d:1.00 (s, 3H), 1.19 (s, 3H), 1.21 (6H, d, J ¼ 7.67 Hz,
2 ꢁ CH3), 2.22–2.44 (m, 2H), 2.55–2.80 (m, 2H), 3.11 (1H,
m, CH), 5.26 (s, 1H), 7.15–7.77 (m, 9H), 8.77 (d, J¼ 7.6 Hz,
1H), 9.33 (s, 1H, NH). 13C NMR (DMSO–d6): d (ppm) ¼
198, 146,140, 137, 134, 132, 128, 126, 124,118, 108, 51, 42,
36, 31, 30, 27, 23. Combustion analysis for C28H29NO:
Calculated (%). C, 85.02; H, 7.39; N, 3.54; found (%): C,
85.01; H, 7.36; N, 3.52.
FT-IR spectra data
10,10-Dimethyl-7-phenyl-7,10,11,12-tetrahydrobenzo[c]-acri-
din-8(9H)-one (4a). IR (KBr, cmꢂ1): 3301 (NH), 3083 (CH-
aromatic), 2956 (CH-aliphatic), 1689 (C ¼ O), 1595 (C ¼ C
aromatic), 1072.
3,3-Dimethyl-9-(4-chlorophenyl)-1,2,3,4,9,10-hexahydro-
benzo-[c]acridine-1-one (4b).
IR (KBr, cmꢂ1): 3334 (NH), 3030 (CH-aromatic), 2958
(CH-aliphatic), 1605 (C ¼ O), 1572 (C ¼ C aromatic), 1492,
1374, 1262, 1148, 1090, 1014, 851, 822, 757.
2-amino-7,7-dimethyl-5-oxo-4-(4-isopropylphenyl)-5,6,7,8-
tetrahydro-4H-chromene-3-carbonitrile (6e): Melting point:
208–2110 ꢀC,: withe powder, IR (KBr/cmꢂ1): 3395, 3324
(NH2), 2199 (CN), 1680 (C ¼ O), 1214 (C-O). 1H NMR
(DMSO–d6): d (ppm) ¼ 0.98 (3H, s, Me), 1.06 (3H, s, Me),
1.23 (6H, d, J ¼ 7.67 Hz, 2 ꢁ CH3), 2.10 (1H, d, J ¼ 16.0 Hz,
H-6), 2.25 (1H, d, J ¼ 16.0 Hz, H-6) , 2.49 (2H, brs, CH2),
3.12 (1H, m, CH), 4.19 (1H, s, H-4), 7.02 (2H, brs, NH2),
3,3-Dimethyl-9-(2,4-dichlorophenyl)-1,2,3,4,9,10-hexahy-
drobenzo[c]acridine-1-one (4c). IR (KBr, cmꢂ1): 3304 (NH),
3065 (CH-aromatic), 2960 (CH-aliphatic), 1684 (C ¼ O),
1590, 1518 (C ¼ C aromatic), 1385, 1262, 1149, 1095, 1037,
880, 807, 754.
3,3-Dimethyl-9-(3-nitrophenyl)-1,2,3,4,9,10-hexahydro-
benzo- [c]acridine-1-one (4d).
IR (KBr, cmꢂ1): 3310 (NH), 3050 (CH-aromatic), 2956 7.10
(2H,
d,
J ¼ 8.24 Hz,H–Ar),
7.13
(2H,
d,
J ¼ 8.24 Hz,H–Ar). 13C NMR (DMSO–d6): d (ppm) ¼ 198,
159, 155, 142,139, 128, 125, 117, 113, 58, 56, 44, 37, 36, 30,
27, 23. Combustion analysis for C21H24N2O2: Calculated
(%). C, 74.97; H, 7.19; N, 8.33; found (%): C, 74.95; H, 7.17;
N, 8.30.
(CH-aliphatic), 1589 (C ¼ O), 1530 (C ¼ C aromatic), 1387,
1262, 1150, 1093, 831, 807, 758, 611.
10,10-Dimethyl-7-(2-phenylethenyl)-7,10,11,12-tetrahydro-
benzo[c]acridin-8(9H)-one (4e). IR (KBr, cmꢂ1): 3342 (NH),
3080 (CH-aromatic), 2956 (CH-aliphatic), 1635 (C ¼ O),
1590, 1557 (C ¼ C aromatic).
N-(4-(2-amino-3-cyano-7,7-dimethyl-5-oxo-5,6,7,8-tetrahy-
dro-4H-chromen-4-yl)phenyl)acetamide (6f): Melting point:
245–247 ꢀC, withe powder, IR (KBr/cm-1): 3395, 3328
(NH2), 2199 (CN), 1680 (C ¼ O), 1667 (C ¼ O), 1214 (C-O).
1H NMR (DMSO–d6): d (ppm) ¼ 0.97 (3H, s, Me), 1.05
(3H, s, Me), 2.00 (3H, s, Me), 2.08 (1H, d, J ¼ 16.0 Hz, H-6),
2.24 (1H, d, J ¼ 16.0 Hz, H-6 0), 2.49 (2H, brs, CH2), 4.10
(1H, s, H-4), 6.98 (2H, brs, NH2), 7.04 (2H, d, J ¼ 8.0 Hz,
H–Ar), 7.24 (2H, d, J ¼ 8.0 Hz, H–Ar), 9.90 (1H, s, NH).
13C NMR (DMSO–d6): d (ppm) ¼ 198, 168,159, 155,
137,135, 128, 121, 117, 113, 58, 51, 44, 37, 30, 27, 22.
Combustion analysis for C20H21N3O3: Calculated (%). C,
68.36; H, 6.02; N, 11.96; found (%): C, 68.32; H, 6.01;
N, 11.93.
10,10-Dimethyl-7-(4-dimethylaminophenyl)-9,10,11,12-tet-
rahydrobenzo[c]acridin-8(7H)-one (4f). IR (KBr, cmꢂ1): 3321
(NH), 3066 (CH-aromatic), 2898 (CH-aliphatic), 1666
(C ¼ O), 1577, 1522 (C ¼ C aromatic), 1435, 1140, 815.
10,10-Dimethyl-7-(2-hydroxyphenyl)-7,10,11,12-tetrahydro-
benzo[c]acridin-8(9H)-one (4 g). IR (KBr, cmꢂ1): 3500 (NH),
3100 (CH-aromatic), 2997 (CH-aliphatic), 1641 (C ¼ O),
1587, 1515 (C ¼ C aromatic), 1487, 1409, 1260, 1175, 1143,
1026, 845, 819, 755, 746.
7,10,10-Trimethyl-9,10,11,12- tetrahydrobenzo[c]acridin-
8(7H)-one (4 h). IR (KBr, cmꢂ1): 3336 (NH), 3087 (CH-aro-
matic), 2987 (CH-aliphatic), 1643 (C ¼ O), 1543, 1532
(C ¼ C aromatic), 1465, 1132, 818.
7-(3-Hydroxyphenyl)-10,10-dimethyl-7,10,11,12-tetrahydro-
benzo[c]acridin-8(9H)-one (4i). IR (KBr, cmꢂ1): 3314 (NH),
3070 (CH-aromatic), 2956 (CH-aliphatic), 1640 (C ¼ O),
1550, 1520 (C ¼ C aromatic), 1468, 1047.
Disclosure statement
No potential conflict of interest was reported by the authors.
2-amino-7,7-dimethyl-5-oxo-4-phenyl-5,6,7,8-tetrahydro-
4H-chromene-3-carbonitrile (6a). IR (KBr/cmꢂ1): 3395, 3324
(NH2), 2199 (CN), 1680 (C ¼ O), 1214 (C-O).
References
2-Amino-7,7-dimethyl-4-(3-nitrophenyl)-5-oxo-5,6,7,8-tet-
rahydro-4H-chromene-3-carbonitrile (6 b). IR (KBr/cmꢂ1):
3429, 3334 (NH2), 2186 (CN), 1680 (C ¼ O), 1210 (C-O).
Ethyl 6-amino-4-(4-methylphenyl)-5-cyano-2- methyl -4H-
pyran-3-carboxylate (6c). IR (KBr/cm- 1): 3382, 3316 (NH2),
2192 (CN), 1682 (C ¼ O), 1213 (C-O).
1. Baguley, B. C.; Zhuang, L.; Marshall, E. M. Experimental Solid
Tumour Activity of N-[2-(dimethylamino)ethyl]-acridine-4-car-
boxamide. Cancer Chemother. Pharmacol. 1995, 36, 244–248.
2. Delcey, M. C.; Croisy, A.; Zajdela, F.; Lhoste, J. M. Synthesis and
Carcinogenic Activity of Oxidized Benzacridines: Potential
Metabolites of the Strong Carcinogen 7-methylbenz[c]Acridine
and of the Inactive Isomer 12-methylbenz[a]Acridine. J. Med.
2-Amino-4-(4-methoxyphenyl)-7,7-dimethyl-5-oxo-5,6,7,8-
tetrahydro-4H-chromene-3-carbonitrile (6d). IR (KBr/cm- 1):
3378, 3319 (NH2), 2196 (CN), 1680 (C ¼ O), 1217 (C-O).